SERGIO
PINAR SUEIRO
Forscher bis um 2022
Hospital de Cruces
Barakaldo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital de Cruces (9)
2015
-
Metabolomics in non-arteritic anterior ischemic optic neuropathy patients by liquid chromatography–quadrupole time-of-flight mass spectrometry
Metabolomics, Vol. 11, Núm. 2, pp. 468-476
2013
-
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat
Experimental Eye Research, Vol. 110, pp. 55-58
2012
-
Dacryocystitis: Systematic approach to diagnosis and therapy
Current Infectious Disease Reports, Vol. 14, Núm. 2, pp. 137-146
-
Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats
Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156
2011
-
Current trends in glaucoma: What's about neuroprotection?
Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 149-174
-
Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model
Clinical and Experimental Ophthalmology, Vol. 39, Núm. 8, pp. 799-807
-
Review of tumours of the paranasal sinuses based on 14 cases
Brain Cancer, Tumor Targeting and Cervical Cancer (Nova Science Publishers, Inc.), pp. 261-276
2010
-
Optic neuropathy in methylmalonic acidemia: The role of neuroprotection
Journal of Inherited Metabolic Disease, Vol. 33, Núm. SUPPL. 3
-
Study on the effectiveness of antibiotic prophylaxis in external dacryocystorhinostomy: A review of 697 cases
Ophthalmic Plastic and Reconstructive Surgery, Vol. 26, Núm. 6, pp. 467-472